http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201300373-A1

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201300373-A1
titleOfInvention ANTIOXIDANT PHARMACEUTICAL COMPOSITION (OPTIONS)
abstract The invention relates to the field of pharmaceutical industry, medicine. The present invention is the creation of an effective antioxidant pharmaceutical composition. The problem is solved due to the fact that the antioxidant pharmaceutical composition containing methylethylpyridinol hydrochloride, additionally contains minerals, and also contains carbon isotopes and nitrogen isotopesN. The invention is described in four embodiments. The technical results of the invention are to increase the shelf life of the pharmaceutical composition; increase therapeutic effect, as well as the rate of onset of therapeutic effect.
priorityDate 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447466490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117653902

Total number of triples: 19.